Strumento inattivo

Azioni Steadymed Ltd

Azioni

Durata

Periodo

Stile

United Therapeutics Corporation : Completes Acquisition Of SteadyMed Ltd.	30/08/18
SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results	14/08/18
SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics	31/07/18
Steadymed : HSR Act Waiting Period Terminated for United Therapeutics' Acquisition of SteadyMed Ltd.	20/07/18
HSR Act Waiting Period Terminated for United Therapeutics’ Acquisition of SteadyMed Ltd.	20/07/18

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 Mrd
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 Mrd
ARGENX SE	+1,69%	22,15 Mrd
BIONTECH SE	-17,37%	21,02 Mrd
GENMAB A/S	-9,30%	18,15 Mrd
WUXI APPTEC CO., LTD.	-41,01%	16,74 Mrd
BEIGENE, LTD.	-14,85%	16,05 Mrd
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 Mrd
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 Mrd